Intraperitoneal Dialysis Solution
Formulations: - Solution: of appropriate composition in accordance with local clinical guidelines. Indications: - Care involving peritoneal dialysis Source: EML workbook import

Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.
Formulations: - Solution: of appropriate composition in accordance with local clinical guidelines. Indications: - Care involving peritoneal dialysis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 6% injectable solution Indications: - Hypovolaemia Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 3.5% injectable solution Parenteral > General injections > IV: 3.5% in solution Indications: - Hypovolaemia Source: EML workbook import
Formulations: - Oral > Solid: 5 mg Indications: - Excessive menstruation with irregular cycle Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 1 g in vial (as sulfate tosylate) powder for injection Indications: - Carbapenem-resistant Pseudomonas aeruginosa - Carbapenem resistant Enterobacterales Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 2 g in vial + 0.5 g in vial powder for injection Indications: - Carbapenem-resistant Pseudomonas aeruginosa - Carbapenem resistant Enterobacterales Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 1 g + 0.5 g powder for injection Indications: - Carbapenem-resistant Pseudomonas aeruginosa Source: EML workbook import
Formulations: - Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) Parenteral > General injections > unspecified: 1 million IU in vial (as colistemethate sodium) (equivalent to 34 mg colistin base activity) Indications: - Other specified bacterial diseases - Carbapenem resistant Acinetobacter baumannii - Carbapenem-resistant Pseudomonas aeruginosa - Carbapenem resistant Enterobacterales Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection Indications: - Other specified bacterial diseases - Carbapenem resistant Acinetobacter baumannii - Carbapenem-resistant Pseudomonas aeruginosa - Carbapenem resistant Enterobacterales Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 1 g in vial + 1 g in vial powder for injection Indications: - Carbapenem-resistant Pseudomonas aeruginosa - Carbapenem resistant Enterobacterales - Carbapenem resistant Acinetobacter baumannii Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 500 mg per 10 mL Indications: - Carbapenem resistant Acinetobacter baumannii - Carbapenem-resistant Pseudomonas aeruginosa - Carbapenem resistant Enterobacterales Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 500000 IU in vial powder for injection (equivalent to 50 mg polymyxin B base) Indications: - Carbapenem resistant Acinetobacter baumannii - Carbapenem-resistant Pseudomonas aeruginosa - Carbapenem resistant Enterobacterales Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.